Amparo
Biomatter is revolutionizing enzyme design through its Intelligent Architecture™ platform, enabling precise control over protein design for health and sustainable manufacturing. They offer a unique product scope, minimizing experimental iterations and reducing time to market. Biomatter provides flexible partnership models and end-to-end solutions from concept to scale-up. Their platform has been used to create reimaged proteins including Glycosyltransferases, DNA-dependent RNA polymerases, and Protein Binders. They partner with leading companies to create unique products and technologies. Biomatter's AI-designed enzymes have been recognized in innovation awards, and they have secured significant seed funding to advance their generative AI capabilities in enzyme design.
Amparo
Biomatter is revolutionizing enzyme design through its Intelligent Architecture™ platform, enabling precise control over protein design for health and sustainable manufacturing. They offer a unique product scope, minimizing experimental iterations and reducing time to market. Biomatter provides flexible partnership models and end-to-end solutions from concept to scale-up. Their platform has been used to create reimaged proteins including Glycosyltransferases, DNA-dependent RNA polymerases, and Protein Binders. They partner with leading companies to create unique products and technologies. Biomatter's AI-designed enzymes have been recognized in innovation awards, and they have secured significant seed funding to advance their generative AI capabilities in enzyme design.